Two Sigma Securities’s Yarrow Bioscience YARW Stock Holding History

Two Sigma Securities’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.5K	Buy	+814	New	+$26.4K	﹤0.01%	1456
2023 Q1	–	Sell	-21	Closed	-$2.83K	–	3334
2022 Q4	$2.83K	Buy	+21	New	+$4.2K	﹤0.01%	2494
2022 Q3	–	Sell	-142	Closed	-$50K	–	3154
2022 Q2	$50K	Buy	+142	New	+$59.6K	﹤0.01%	1847
2022 Q1	–	Sell	-53	Closed	-$48K	–	2552
2021 Q4	$48K	Buy	+53	New	+$56.9K	﹤0.01%	1281

Other funds holding YARW

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Securities's YARW Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Yarrow Bioscience (YARW) in Q2 2026: 814 shares worth $26.5K. The stake represents ﹤0.01% of the portfolio and ranks #1456 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in YARW as recently as Q4 2022.

Two Sigma Securities first reported a position in YARW in Q4 2021 and has held it in 4 quarters since. The position peaked at $50K in Q2 2022. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

Two Sigma Securities held 814 shares of Yarrow Bioscience worth $26.5K as of Q2 2026.
Yarrow Bioscience was a new Two Sigma Securities position in Q2 2026.
Yarrow Bioscience made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1456 holding.
Two Sigma Securities first reported a position in Yarrow Bioscience in Q4 2021 and has held it in 4 quarters since.
Two Sigma Securities's Yarrow Bioscience position peaked at $50K in Q2 2022.
40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.